Immuron ASX IMC CEO Insights Commercial Progress and What’s next
Published July 28, 2026
Views 131 | Likes 0 | Comments 0
At a glance
Views
131
Likes
0
Comments
0
Performance vs. channel
Outlier score
Engagement rate
More features coming
We're working on new analytics and tools. Stay tuned.
About
Join Kalkine Media’s Invest Nest Webinar featuring Steven Lydeamore, CEO of Immuron Limited (ASX:IMC) (NASDAQ:IMRN), as he discusses the company’s commercial progress, growth strategy, and future opportunities in the rapidly expanding digestive health market. Immuron is an Australian biopharmaceutical company focused o…
- Published
- July 28, 2026
- Made for kids
- No
More features coming
We're working on new analytics and tools. Stay tuned.